نوع مقاله : مقاله های پژوهشی
نویسندگان
1 استاد، گروه پاتولوژی، دانشکدهی پزشکی، مرکز تحقیقات بیماریهای عفونی و گرمسیری، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران
2 استاد، گروه داخلی اعصاب، دانشکدهی پزشکی، مرکز تحقیقات علوم اعصاب، مرکز آموزشی درمانی آیت الله کاشانی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران
3 دانشکدهی پزشکی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران
چکیده
تازه های تحقیق
آذر برادران: Google Scholar
وحید شایگان پور: Google Scholar
کلیدواژهها
موضوعات
عنوان مقاله [English]
نویسندگان [English]
Background: Given the increased levels of the hormone leptin in some autoimmune and inflammatory diseases, including multiple sclerosis (MS) as a chronic progressive disease, the present study was conducted to determine and compare the mean serum level of leptin in patients with Relapsing-Remitting Multiple Sclerosis (RRMS) and Secondary Progressive Multiple Sclerosis (SPMS).
Methods: In this cross-sectional study conducted in 2021 at Kashani Hospital in Isfahan, 16 patients with RRMS and 16 patients with SPMS were selected according to the 2015 McDonald criteria. Leptin serum levels were evaluated in the two groups using a leptin kit from the LDN company and the ELISA method, and compared using the Chi-square and Mann-Whitney statistical tests.
Findings: The median leptin serum level in the RRMS and SPMS groups was 29.5 (15.5- 34.75), and 42 (35.25-46.75) respectively, and the difference between the scores of the two groups was significant (P = 0.003). Other findings showed no significant correlation between leptin serum levels and age, BMI, or EDSS.
Conclusion: Based on the results of the study, serum leptin levels in patients with multiple sclerosis could potentially be introduced as a biomarker and used for better diagnosis and follow-up of patients.
کلیدواژهها [English]